ARL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.975800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.566000E-01
Normal-vs-Stage2
5.932000E-01
Normal-vs-Stage3
7.275600E-01
Normal-vs-Stage4
4.419200E-01
Stage1-vs-Stage2
1.215410E-01
Stage1-vs-Stage3
1.054980E-01
Stage1-vs-Stage4
5.927800E-01
Stage2-vs-Stage3
2.913600E-01
Stage2-vs-Stage4
5.970400E-01
Stage3-vs-Stage4
1.997570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.042000E-01
Normal-vs-AfricanAmerican
4.219000E-01
Normal-vs-Asian
9.988000E-01
Caucasian-vs-AfricanAmerican
6.263800E-01
Caucasian-vs-Asian
3.254200E-01
AfricanAmerican-vs-Asian
2.010800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.550800E-01
Normal-vs-Female
6.243600E-01
Male-vs-Female
7.175600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.580400E-01
Normal-vs-Age(41-60Yrs)
4.864200E-01
Normal-vs-Age(61-80Yrs)
6.543400E-01
Normal-vs-Age(81-100Yrs)
7.701800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.163800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.279400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.860000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.996400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.205000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.338600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.512200E-01
Normal-vs-Daily Drinker
9.308800E-01
Normal-vs-Weekly Drinker
8.466800E-01
Normal-vs-Occasional Drinker
3.330200E-01
Normal-vs-Social Drinker
5.239800E-01
Non Drinker-vs-Daily Drinker
9.396400E-01
Non Drinker-vs-Weekly Drinker
7.665600E-01
Non Drinker-vs-Occasional Drinker
3.765900E-02
Non Drinker-vs-Social Drinker
1.714760E-01
Daily Drinker-vs-Weekly Drinker
8.389800E-01
Daily Drinker-vs-Occasional Drinker
4.434000E-02
Daily Drinker-vs-Social Drinker
1.802590E-01
Weekly Drinker-vs-Occasional Drinker
1.125190E-01
Weekly Drinker-vs-Social Drinker
2.072200E-01
Occasional Drinker-vs-Social Drinker
5.885200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.545400E-01
Normal-vs-Grade 2
7.441900E-02
Normal-vs-Grade 3
1.049440E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.678800E-01
Grade 1-vs-Grade 3
2.274400E-01
Grade 1-vs-Grade 4
3.545400E-01
Grade 2-vs-Grade 3
7.185800E-01
Grade 2-vs-Grade 4
7.441900E-02
Grade 3-vs-Grade 4
1.049440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.981800E-01
Normal-vs-NonDiabetic
6.623800E-01
Diabetic-vs-NonDiabetic
2.386600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.767800E-01
Normal-vs-NoPancreatitis
6.552600E-01
Pancreatitis-vs-NoPancreatitis
6.521900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.790400E-01
Normal-vs-N1
5.961800E-01
N0-vs-N1
2.201200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.012200E-01
Normal-vs-TP53-NonMutant
5.120200E-01
TP53-Mutant-vs-TP53-NonMutant
2.577400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
